Ting Jiang

466 total citations
20 papers, 339 citations indexed

About

Ting Jiang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Ting Jiang has authored 20 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Ting Jiang's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and RNA Research and Splicing (5 papers). Ting Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and RNA Research and Splicing (5 papers). Ting Jiang collaborates with scholars based in China, United Kingdom and Canada. Ting Jiang's co-authors include Yanke Chen, Chen Huang, Zhenghao Zhao, Huan Yang, Ye Li, Desheng Liang, Bing Qin, Bo Xiao, Ni Hou and Zhenzhen Wang and has published in prestigious journals such as Cell Death and Differentiation, European Journal of Pharmacology and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Ting Jiang

19 papers receiving 338 citations

Peers

Ting Jiang
Lian He China
Weimin Dong China
Richard A. Veldhoen Canada
Vinay Raj United States
Jiazhuan Mei China
Muhammad Yogi Pratama Indonesia
Zheyue Shu China
Yiming Lei China
Lian He China
Ting Jiang
Citations per year, relative to Ting Jiang Ting Jiang (= 1×) peers Lian He

Countries citing papers authored by Ting Jiang

Since Specialization
Citations

This map shows the geographic impact of Ting Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Jiang more than expected).

Fields of papers citing papers by Ting Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Jiang. The network helps show where Ting Jiang may publish in the future.

Co-authorship network of co-authors of Ting Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ting Jiang. A scholar is included among the top collaborators of Ting Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Jiang. Ting Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Ting, et al.. (2025). Inhibition of UCH-L1 enhances immunotherapy efficacy in triple-negative breast cancer by stabilizing PD-L1. European Journal of Pharmacology. 1000. 177743–177743.
2.
Gong, Rong, Shilong Jiang, Yidi Guan, et al.. (2025). GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62. Cell Death and Differentiation. 32(11). 2022–2037. 7 indexed citations
3.
Han, Cong, Qian Li, Fang Li, et al.. (2023). IGF2BP3-EGFR-AKT axis promotes breast cancer MDA-MB-231 cell growth. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(8). 119542–119542. 5 indexed citations
4.
Jiang, Ting, Jinfeng Chen, Zhenzhen Wang, et al.. (2023). miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway. Breast Cancer. 30(5). 691–702. 2 indexed citations
5.
Li, Xiaojun, et al.. (2023). Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer. Cell Death and Disease. 14(10). 665–665. 8 indexed citations
6.
Liu, Xinning, et al.. (2023). Integration analysis using bioinformatics and experimental validation on the clinical and biological significance of TSLP in cancers. Cellular Signalling. 111. 110874–110874. 2 indexed citations
7.
Jiang, Ting, et al.. (2023). A new C 22 polyacetylene and seven isoprenylated pterocarpans from Erythrina subumbrans. Journal of Asian Natural Products Research. 26(3). 394–398. 1 indexed citations
8.
Li, Yi‐Zhi, et al.. (2022). Identification of KCNK1 as a potential prognostic biomarker and therapeutic target of breast cancer. Pathology - Research and Practice. 241. 154286–154286. 7 indexed citations
9.
Chen, Yanke, Jing Luan, Ting Jiang, et al.. (2020). Knockdown of EMMPRIN (OX47) in MRMT-1 Carcinoma Cells Inhibits Tumor Growth and Decreases Cancer-Induced Bone Destruction and Pain. Cancer Research and Treatment. 53(2). 576–583. 3 indexed citations
10.
Ren, Kun, Xiaodan Xu, Mengqi Li, et al.. (2020). LncRNA-modulated autophagy in plaque cells: a new paradigm of gene regulation in atherosclerosis?. Aging. 12(21). 22335–22349. 7 indexed citations
11.
Wang, Zhenzhen, Dongdong Tong, Cong Han, et al.. (2019). Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation. EBioMedicine. 41. 357–369. 72 indexed citations
12.
13.
Jiang, Ting & Daozhen Chen. (2016). Decreased miR-320 and increased AQP1 in patients with breast cancer and the clinical significance. Journal of Molecular Biomarkers & Diagnosis. 1 indexed citations
14.
Liu, Na, Zhenghao Zhao, Jia Han, et al.. (2016). MicroRNA-302a enhances 5-fluorouracil-induced cell death in human colon cancer cells. Oncology Reports. 37(1). 631–639. 30 indexed citations
15.
Jiang, Ting, Weihong Zhang, Chunyu Li, et al.. (2016). Predictors of mortality in bloodstream infections caused by multidrug-resistant gram-negative bacteria: 4 years of collection. American Journal of Infection Control. 45(1). 59–64. 26 indexed citations
16.
Chen, Yanke, Xiaofei Wang, Jiwen Cheng, et al.. (2016). MicroRNA-20a-5p targets RUNX3 to regulate proliferation and migration of human hepatocellular cancer cells. Oncology Reports. 36(6). 3379–3386. 33 indexed citations
17.
Wang, Zhenzhen, Zhenghao Zhao, Ting Jiang, Yanke Chen, & Chen Huang. (2016). The Multistep Functions of EMMPRIN/ CD147 in the Tumor Angiogenesis. 2(1). 4 indexed citations
18.
Zhou, Xin, Wei Wen, Xia Shan, et al.. (2015). MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism. Thrombosis Research. 138. 91–95. 51 indexed citations
19.
Cui, Xiang‐Shun, Le Wang, Fei Liu, et al.. (2014). The Mitochondrial Thioredoxin is Required for Liver Development in Zebrafish. Current Molecular Medicine. 14(6). 772–782. 9 indexed citations
20.
Qin, Bing, Bo Xiao, Desheng Liang, et al.. (2012). MicroRNA let-7c inhibits Bcl-xl expression and regulates ox-LDL-induced endothelial apoptosis. BMB Reports. 45(8). 464–469. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lian He Breakdown of academic impact, for papers by Weimin Dong Breakdown of academic impact, for papers by Richard A. Veldhoen Breakdown of academic impact, for papers by Vinay Raj Breakdown of academic impact, for papers by Jiazhuan Mei Breakdown of academic impact, for papers by Muhammad Yogi Pratama Breakdown of academic impact, for papers by Zheyue Shu Breakdown of academic impact, for papers by Yiming Lei
Rankless by CCL
2026